Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”

Saved in:
Bibliographic Details
Main Authors: Vanessa Fairhurst, Randa Salah Gomaa Mahmoud, Toba Olatoye, Sylvester Sakilay
Format: Article
Language:English
Published: JMIR Publications 2025-01-01
Series:JMIRx Med
Online Access:https://xmed.jmir.org/2025/1/e71293
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575861706981376
author Vanessa Fairhurst
Randa Salah Gomaa Mahmoud
Toba Olatoye
Sylvester Sakilay
author_facet Vanessa Fairhurst
Randa Salah Gomaa Mahmoud
Toba Olatoye
Sylvester Sakilay
author_sort Vanessa Fairhurst
collection DOAJ
format Article
id doaj-art-64b37b0e763d41fd9360409953679ebb
institution Kabale University
issn 2563-6316
language English
publishDate 2025-01-01
publisher JMIR Publications
record_format Article
series JMIRx Med
spelling doaj-art-64b37b0e763d41fd9360409953679ebb2025-01-31T17:02:30ZengJMIR PublicationsJMIRx Med2563-63162025-01-016e71293e7129310.2196/71293Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”Vanessa FairhurstRanda Salah Gomaa Mahmoudhttp://orcid.org/0000-0001-5463-084XToba Olatoyehttp://orcid.org/0009-0005-9199-2037Sylvester Sakilayhttp://orcid.org/0000-0002-6684-6311https://xmed.jmir.org/2025/1/e71293
spellingShingle Vanessa Fairhurst
Randa Salah Gomaa Mahmoud
Toba Olatoye
Sylvester Sakilay
Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
JMIRx Med
title Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
title_full Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
title_fullStr Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
title_full_unstemmed Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
title_short Peer Review of “Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Recurrent Glioblastoma: An Augmented Meta-Analysis of Phase 1 Clinical Trials (Preprint)”
title_sort peer review of safety and efficacy of chimeric antigen receptor t cell therapy for recurrent glioblastoma an augmented meta analysis of phase 1 clinical trials preprint
url https://xmed.jmir.org/2025/1/e71293
work_keys_str_mv AT vanessafairhurst peerreviewofsafetyandefficacyofchimericantigenreceptortcelltherapyforrecurrentglioblastomaanaugmentedmetaanalysisofphase1clinicaltrialspreprint
AT randasalahgomaamahmoud peerreviewofsafetyandefficacyofchimericantigenreceptortcelltherapyforrecurrentglioblastomaanaugmentedmetaanalysisofphase1clinicaltrialspreprint
AT tobaolatoye peerreviewofsafetyandefficacyofchimericantigenreceptortcelltherapyforrecurrentglioblastomaanaugmentedmetaanalysisofphase1clinicaltrialspreprint
AT sylvestersakilay peerreviewofsafetyandefficacyofchimericantigenreceptortcelltherapyforrecurrentglioblastomaanaugmentedmetaanalysisofphase1clinicaltrialspreprint